90 related articles for article (PubMed ID: 26760812)
1. Acute myeloid leukemia: update in diagnosis and treatment in Brazil.
Helman R; Santos FP; Simões B; Atta EH; Callera F; Dobbin Jde A; Mattos ÉR; Atalla A; Maiolino A; Zanichelli MA; Diefenbach CF; Delamain MT; Hamerschlak N
Einstein (Sao Paulo); 2011 Jun; 9(2):179-83. PubMed ID: 26760812
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia.
Emerenciano M; Agudelo Arias DP; Coser VM; de Brito GD; Macedo Silva ML; Pombo-de-Oliveira MS;
Pediatr Blood Cancer; 2006 Oct; 47(5):549-54. PubMed ID: 16261608
[TBL] [Abstract][Full Text] [Related]
3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
4. [The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia].
Tang X; Wu D; Xue Y; Zhu M; Lu D; Ruan C
Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):685-7. PubMed ID: 12485536
[TBL] [Abstract][Full Text] [Related]
5. [Acute myeloid leukemia in the adult. Results of the National Antineoplastic Drug Protocol at the Hospital del Salvador, 1990-1998].
Puga BL; Cabrera ME; Undurraga MS; Etcheverry R; Vacarezza R; Ducach G; Toledo H
Rev Med Chil; 2000 Nov; 128(11):1191-8. PubMed ID: 11347505
[TBL] [Abstract][Full Text] [Related]
6. [Immunophenotyping of childhood leukemias--results of the first 100 bone marrow tests].
Klujber V; Koós R; Schuler D; Bocsi J
Orv Hetil; 1996 May; 137(21):1139-42. PubMed ID: 8757108
[TBL] [Abstract][Full Text] [Related]
7. [Study on the clinical characteristics of 32 patients with mixed phenotype acute leukemia].
Zhang YM; Wu DP; Sun AN; Qiu HY; Sun YM; He GS; Jin ZM; Tang XW; Miao M; Fu ZZ; Han Y; Chen SN; Zhu MQ
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):12-6. PubMed ID: 21429394
[TBL] [Abstract][Full Text] [Related]
8. Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings.
Voskova D; Schoch C; Schnittger S; Hiddemann W; Haferlach T; Kern W
Cytometry B Clin Cytom; 2004 Nov; 62(1):25-38. PubMed ID: 15468339
[TBL] [Abstract][Full Text] [Related]
9. Reliability and limitations of cytochemistry in diagnosis of acute myeloid leukemia. Minireview.
Klobusická M
Neoplasma; 2000; 47(6):329-34. PubMed ID: 11263855
[TBL] [Abstract][Full Text] [Related]
10. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
11. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
Meloni G; Russo D; Baccarani M; Testoni N; Martinelli G; Fanin R; Zuffa E; Rosti G; Alimena G; Saglio G; Mandelli F; Tura S
Haematologica; 1999 Aug; 84(8):707-15. PubMed ID: 10457406
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.
Cassileth PA; Harrington DP; Appelbaum FR; Lazarus HM; Rowe JM; Paietta E; Willman C; Hurd DD; Bennett JM; Blume KG; Head DR; Wiernik PH
N Engl J Med; 1998 Dec; 339(23):1649-56. PubMed ID: 9834301
[TBL] [Abstract][Full Text] [Related]
14. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
Cui W; Zhang D; Cunningham MT; Tilzer L
Int J Lab Hematol; 2014 Dec; 36(6):636-49. PubMed ID: 24602197
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotyping of acute myeloid leukemia cells.
Ball ED
Clin Lab Med; 1990 Dec; 10(4):721-36. PubMed ID: 2272171
[TBL] [Abstract][Full Text] [Related]
16. [Acute myeloid leukemia MO: clinical and laboratory characteristics].
Cabrera E; Rojas B; Labra S; Matutes E; Puga B
Rev Med Chil; 1997 Apr; 125(4):433-7. PubMed ID: 9460284
[TBL] [Abstract][Full Text] [Related]
17. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
[TBL] [Abstract][Full Text] [Related]
18. Influence of aberrant myeloid expression on acute lymphoblastic leukemia in children and adolescents from Maranhão, Brazil.
Lopes TC; Andrade KN; Camelo NL; Rodrigues VP; Oliveira RA
Genet Mol Res; 2014 Dec; 13(4):10301-7. PubMed ID: 25501242
[TBL] [Abstract][Full Text] [Related]
19. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
20. [MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression].
Wu WL; Liang JY; Zhu MQ; Xue YQ; Chen ZX
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):754-6. PubMed ID: 18457267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
